NCT02797925

Brief Summary

There has been an increasing amount of musculoskeletal injuries the past decades and overused tendons represents a major problem both for leisure and occupational activities. A full understanding of the pathophysiology of tendinopathy is very sparse and especially the early events in tendinopathy remains unexplained. In this phd study the investigators will investigate early changes in tendon tissue overloading and development of tendinopathy. The investigators will investigate sports-active individuals with recently developed tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography, MRI and electron microscopy), tendon mechanical properties (ultrasonography strain), tissue molecular biology (expression and content of matrix proteins), inflammation (activity of inflammatory pathways) and vascularization (Doppler and contrast enhancement US). The investigators hypothesize a coupling between early symptoms and inflammatory activity, followed by structural changes and altered mechanical properties. The investigation will indicate what symptoms and what tendon related determined measurements are primary for disease development ("tendinopathy blue prints") and should be regarding vital in prevention of tendinopathy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 2, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 14, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

January 19, 2018

Status Verified

January 1, 2018

Enrollment Period

3 years

First QC Date

June 2, 2016

Last Update Submit

January 18, 2018

Conditions

Keywords

Achilles tendonPatella tendonInflammationEdemaClinicalStructural

Outcome Measures

Primary Outcomes (1)

  • Investigate the timespan of inflammation from acute phase to resolution in tendinopathy

    Markers for inflammation includes tendon thickness, vascularization, inflammatory mRNA leves, inflammatory protein signals and mechanical properties of tendon.

    3 months

Secondary Outcomes (6)

  • Measure tendon thickness in mm (anterior-posterior) on ultrasound

    3 months

  • Measure TNF-alpha mRNA levels in patella biopsies as ratio to GAPDH

    3 months

  • Measure the tendon region with maximal vascularization on ultrasound doppler signal based on visual impression from the investigators

    3 months

  • IHC stain for TNF-alpha protein signal in patella biopsies with specific antibodies

    3 month

  • Measure tendon mechanical properties with ultrasound isometric

    3 months

  • +1 more secondary outcomes

Study Arms (2)

Tendinopathy

Long slow strength training for 3 months that are performed at home or gym. Participants receive initial guidance to the exercises from a physiotherapist assigned to Bispebjerg H.

Other: Training

Healthy

No intervention. No training

Interventions

Long slow strength training of the tendon for 3 months to improve function

Also known as: Long slow strength training
Tendinopathy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Physical active participants over 18 years old, both men and women. The term physical active refers to any kind of sport and not only running. Participants with pain in either Achilles or patellar tendon on one leg. Healthy participants must be symptom free and not have any diseases at all.

You may qualify if:

  • Marked tendon related pain in association with exercise on one leg
  • Soreness during physical examination of patella or/and Achilles tendon upon palpation
  • Demonstrate an ultrasonographic (US) thickening of the tendon (2 mm larger on the affected side vs the contralateral un-symptomatic side in the anterior-posterior projection)

You may not qualify if:

  • Surgery in Achilles and/or patella tendon
  • History of Achilles and/or patella tendinopathy
  • Received any form of injection in Achilles and/or patella tendon
  • Lately have infection around Achilles and/or patella tendon

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg Hospital

Copenhagen, Kbh NV, 2400, Denmark

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum, plasma and tissue.

MeSH Terms

Conditions

TendinopathyInflammationEdema

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Michael Kjær, Professor

    Clinical Medicine

    STUDY DIRECTOR

Central Study Contacts

Peter Tran, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor, phd student

Study Record Dates

First Submitted

June 2, 2016

First Posted

June 14, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2019

Study Completion

June 1, 2020

Last Updated

January 19, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations